Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

8.60
+0.01000.12%
Pre-market: 8.770.1700+1.98%04:58 EST
Volume:5.26M
Turnover:44.60M
Market Cap:1.19B
PE:-3.87
High:8.88
Open:8.53
Low:8.05
Close:8.59
52wk High:15.87
52wk Low:4.88
Shares:138.00M
Float Shares:107.00M
Volume Ratio:0.86
T/O Rate:4.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2247
EPS(LYR):-3.0800
ROE:-296.45%
ROA:-32.83%
PB:8.35
PE(LYR):-2.79

Loading ...

COMPASS Pathways (CMPS) Nears COMP360 NDA Submission, Is It Still A Bargain?

Simply Wall St.
·
4 hours ago

Compass Pathways Remains on Track for COMP360 Launch Following Q3 Results, RBC Says

MT Newswires Live
·
17 hours ago

Nuvectis Pharma Q3 Net Loss Widens on Licensing and R&D Costs

Reuters
·
Yesterday

Compass Pathways Price Target Maintained with a $25.00/Share by BTIG

Dow Jones
·
Nov 03

Compass Pathways PLC Reports Results for the Quarter Ended September 30 - Earnings Summary

Reuters
·
Nov 03

Top Premarket Gainers

MT Newswires Live
·
Nov 03

Earnings Flash (CMPS) Compass Pathways Posts Q3 Loss $0.31 a Share, vs. FactSet Est of $0.39 Loss

MT Newswires Live
·
Nov 03

Compass Pathways Q3 EPS $(0.31) Beats $(0.43) Estimate

Benzinga Earnings
·
Nov 03

Compass Pathways Q3 Net Loss Narrows 93% to USD 9.83 Million

Reuters
·
Nov 03

Compass Pathways Q3 Operating Expenses USD 56.437 Million

THOMSON REUTERS
·
Nov 03

Compass Pathways - Cash Position Expected to Fund Operations and Capex into 2028

THOMSON REUTERS
·
Nov 03

Corrected-Compass Pathways Q3 EPS USD -0.31 (Corrects Amount)

THOMSON REUTERS
·
Nov 03

Compass Pathways Announces Third Quarter 2026 Financial Results and Business Highlights

THOMSON REUTERS
·
Nov 03

Psychedelic Drug Developers Fall After Usona Submits Depressive Drug Application

Reuters
·
Nov 03

Compass Pathways Survey Finds 95% of Treatment-Resistant Depression Patients Struggle with Daily Life

Reuters
·
Nov 02

Compass Pathways PLC Expected to Post a Loss of 45 Cents a Share - Earnings Preview

Reuters
·
Oct 30

Compass Pathways Presents Comp360 Psilocybin Research at NEI Fall Congress

Reuters
·
Oct 28

Compass Pathways to Report Third-Quarter Financial Results

Reuters
·
Oct 27

Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026

THOMSON REUTERS
·
Oct 27

COMPASS Pathways (CMPS) Reports Positive Phase 3 Data, Is The Premium Still Justified?

Simply Wall St.
·
Oct 20